Interferon alfa-2a biosimilar (LG Life Sciences)

干扰素α-2b生物类似药（LG Life Sciences）

Report date: 2022/02/21 11:21:15

Base Information

Drug NameInterferon alfa-2a biosimilar (LG Life Sciences)
Drug Alias Nameinterferon alfa-2a follow-on biologic干扰素α-2b生物仿制药（LG Life Sciences）Intermax Alpha
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple MyelomaCarcinoma, Renal CellMelanoma +[8] 
Global Approved IndicationsMultiple MyelomaCarcinoma, Renal CellMelanoma +[8] 
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date1992/12/31
Country/TerritorySouth AmericaSouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaCarcinoma, Renal CellMelanoma +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB04
Related LinksN/A